Jay Shendure News Today

/PRNewswire/ -- Somite Therapeutics, a tech-bio company harnessing big data and AI to pioneer novel cell replacement therapies, is thrilled to announce the...

What Briefing readers think about how doctoral degrees should be evaluated. Plus, the X-factor in bird song that makes males irresistible and why like-charged particles can sometimes attract. What Briefing readers think about how doctoral degrees should be evaluated. Plus, the X-factor in bird song that makes males irresistible and why like-charged particles can sometimes attract.

<p>Unexpected findings have emerged about how and when certain infection-killing white blood cells decide to form memories about their encounters with a pathogen. </p> <p>These cells can turn themselves into durable memory cells that can survive a long time after an initial infection is cleared. They are prepared to recognize and eliminate future intrusions by the same kind of pathogen.</p> <p>That is one reason people are resista...

Reversible switch permits infection-fighting blood cells to change course to become long-lived memory cells instead of short-lived killer cells.

SEATTLE — Seattle will soon get a new health science research center that explores how developments in technology can help biologists better understand the changes in our bodies — and

The Seattle Hub of Synthetic Biology is planning to establish its new research center in the South Lake Union at the Allen Institute.

/PRNewswire/ -- The Allen Institute, the Chan Zuckerberg Initiative (CZI), and the University of Washington (UW) today announced the launch of the Seattle Hub...

In a tour de force for neuroscience, teams of researchers have published a voluminous set of brain-cell atlases for humans and other primates. The atlases are detailed in 21 research papers appearing in Science, Science Advances and Science Translational Medicine — and could point scientists toward new strategies for addressing mental conditions ranging from Alzheimer’s disease and schizophrenia to epilepsy and ADHD. “We need to understand the specifics of the human brain if...

/PRNewswire/ -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2023. Second quarter results Revenue of $47.6 million, a...

/PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of Olga...